Medtronic Reveal XT Study

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Atrial Fibrillation
Interventions
DEVICE

Reveal XT implantation

The implantation of the Reveal XT device will be performed at the time of surgery before the planned median sternotomy or thoracotomy.

Trial Locations (2)

60611

Northwestern University, Chicago

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

Washington University School of Medicine

OTHER

NCT01526343 - Medtronic Reveal XT Study | Biotech Hunter | Biotech Hunter